![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RRS1 |
Gene summary for RRS1 |
![]() |
Gene information | Species | Human | Gene symbol | RRS1 | Gene ID | 23212 |
Gene name | ribosome biogenesis regulator 1 homolog | |
Gene Alias | RRS1 | |
Cytomap | 8q13.1 | |
Gene Type | protein-coding | GO ID | GO:0000027 | UniProtAcc | Q15050 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23212 | RRS1 | LZE2T | Human | Esophagus | ESCC | 1.14e-05 | 4.11e-01 | 0.082 |
23212 | RRS1 | LZE4T | Human | Esophagus | ESCC | 4.09e-07 | 1.85e-01 | 0.0811 |
23212 | RRS1 | LZE7T | Human | Esophagus | ESCC | 2.65e-04 | 4.48e-02 | 0.0667 |
23212 | RRS1 | LZE8T | Human | Esophagus | ESCC | 5.70e-05 | 3.90e-02 | 0.067 |
23212 | RRS1 | LZE24T | Human | Esophagus | ESCC | 1.37e-03 | 1.54e-01 | 0.0596 |
23212 | RRS1 | P2T-E | Human | Esophagus | ESCC | 1.64e-12 | 2.29e-01 | 0.1177 |
23212 | RRS1 | P4T-E | Human | Esophagus | ESCC | 8.78e-10 | 4.44e-01 | 0.1323 |
23212 | RRS1 | P5T-E | Human | Esophagus | ESCC | 7.15e-16 | 3.27e-01 | 0.1327 |
23212 | RRS1 | P8T-E | Human | Esophagus | ESCC | 3.95e-09 | 2.87e-02 | 0.0889 |
23212 | RRS1 | P9T-E | Human | Esophagus | ESCC | 3.41e-10 | 2.79e-01 | 0.1131 |
23212 | RRS1 | P10T-E | Human | Esophagus | ESCC | 2.81e-10 | 2.00e-01 | 0.116 |
23212 | RRS1 | P11T-E | Human | Esophagus | ESCC | 2.67e-03 | 5.34e-01 | 0.1426 |
23212 | RRS1 | P12T-E | Human | Esophagus | ESCC | 1.15e-16 | 2.89e-01 | 0.1122 |
23212 | RRS1 | P15T-E | Human | Esophagus | ESCC | 4.52e-16 | 4.66e-01 | 0.1149 |
23212 | RRS1 | P16T-E | Human | Esophagus | ESCC | 1.48e-16 | 5.65e-01 | 0.1153 |
23212 | RRS1 | P17T-E | Human | Esophagus | ESCC | 7.37e-03 | 3.59e-01 | 0.1278 |
23212 | RRS1 | P20T-E | Human | Esophagus | ESCC | 1.37e-15 | 3.72e-01 | 0.1124 |
23212 | RRS1 | P21T-E | Human | Esophagus | ESCC | 3.70e-22 | 6.37e-01 | 0.1617 |
23212 | RRS1 | P22T-E | Human | Esophagus | ESCC | 7.54e-25 | 4.21e-01 | 0.1236 |
23212 | RRS1 | P23T-E | Human | Esophagus | ESCC | 9.72e-27 | 7.82e-01 | 0.108 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004227322 | Liver | HCC | ribosomal large subunit biogenesis | 64/7958 | 72/18723 | 2.31e-16 | 2.03e-14 | 64 |
GO:002261822 | Liver | HCC | ribonucleoprotein complex assembly | 153/7958 | 220/18723 | 3.44e-16 | 2.91e-14 | 153 |
GO:005116822 | Liver | HCC | nuclear export | 113/7958 | 154/18723 | 6.30e-15 | 4.39e-13 | 113 |
GO:00304901 | Liver | HCC | maturation of SSU-rRNA | 43/7958 | 50/18723 | 2.35e-10 | 8.04e-09 | 43 |
GO:004225522 | Liver | HCC | ribosome assembly | 50/7958 | 61/18723 | 2.79e-10 | 9.50e-09 | 50 |
GO:014001411 | Liver | HCC | mitotic nuclear division | 174/7958 | 287/18723 | 3.74e-10 | 1.23e-08 | 174 |
GO:005165621 | Liver | HCC | establishment of organelle localization | 226/7958 | 390/18723 | 4.15e-10 | 1.34e-08 | 226 |
GO:007233122 | Liver | HCC | signal transduction by p53 class mediator | 108/7958 | 163/18723 | 7.14e-10 | 2.23e-08 | 108 |
GO:00711661 | Liver | HCC | ribonucleoprotein complex localization | 59/7958 | 77/18723 | 1.09e-09 | 3.30e-08 | 59 |
GO:0000070 | Liver | HCC | mitotic sister chromatid segregation | 110/7958 | 168/18723 | 1.42e-09 | 4.25e-08 | 110 |
GO:00008191 | Liver | HCC | sister chromatid segregation | 128/7958 | 202/18723 | 1.59e-09 | 4.73e-08 | 128 |
GO:00714261 | Liver | HCC | ribonucleoprotein complex export from nucleus | 58/7958 | 76/18723 | 1.98e-09 | 5.63e-08 | 58 |
GO:00905011 | Liver | HCC | RNA phosphodiester bond hydrolysis | 101/7958 | 152/18723 | 1.99e-09 | 5.63e-08 | 101 |
GO:0007059 | Liver | HCC | chromosome segregation | 197/7958 | 346/18723 | 3.57e-08 | 7.87e-07 | 197 |
GO:0090305 | Liver | HCC | nucleic acid phosphodiester bond hydrolysis | 152/7958 | 261/18723 | 1.90e-07 | 3.46e-06 | 152 |
GO:190179622 | Liver | HCC | regulation of signal transduction by p53 class mediator | 64/7958 | 93/18723 | 2.53e-07 | 4.45e-06 | 64 |
GO:00315031 | Liver | HCC | protein-containing complex localization | 129/7958 | 220/18723 | 9.38e-07 | 1.42e-05 | 129 |
GO:00004601 | Liver | HCC | maturation of 5.8S rRNA | 29/7958 | 35/18723 | 1.12e-06 | 1.66e-05 | 29 |
GO:00004621 | Liver | HCC | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 30/7958 | 37/18723 | 1.78e-06 | 2.48e-05 | 30 |
GO:0098813 | Liver | HCC | nuclear chromosome segregation | 157/7958 | 281/18723 | 3.82e-06 | 4.95e-05 | 157 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RRS1 | SNV | Missense_Mutation | c.49N>A | p.Glu17Lys | p.E17K | Q15050 | protein_coding | tolerated(0.21) | benign(0.359) | TCGA-GM-A2D9-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | |
RRS1 | SNV | Missense_Mutation | c.854N>T | p.Thr285Ile | p.T285I | Q15050 | protein_coding | tolerated(0.08) | possibly_damaging(0.597) | TCGA-D5-6928-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
RRS1 | deletion | Frame_Shift_Del | c.140delC | p.Pro47ArgfsTer42 | p.P47Rfs*42 | Q15050 | protein_coding | TCGA-D5-6540-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |||
RRS1 | deletion | Frame_Shift_Del | c.135delN | p.Pro47ArgfsTer42 | p.P47Rfs*42 | Q15050 | protein_coding | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |||
RRS1 | deletion | Frame_Shift_Del | c.135delN | p.Pro47ArgfsTer42 | p.P47Rfs*42 | Q15050 | protein_coding | TCGA-WS-AB45-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |||
RRS1 | SNV | Missense_Mutation | novel | c.410N>A | p.Ser137Asn | p.S137N | Q15050 | protein_coding | tolerated(0.53) | benign(0.046) | TCGA-AJ-A3EK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
RRS1 | SNV | Missense_Mutation | novel | c.1031C>T | p.Ser344Phe | p.S344F | Q15050 | protein_coding | deleterious_low_confidence(0.02) | benign(0.062) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
RRS1 | SNV | Missense_Mutation | novel | c.247N>T | p.Arg83Cys | p.R83C | Q15050 | protein_coding | deleterious(0) | possibly_damaging(0.825) | TCGA-AX-A3FS-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
RRS1 | SNV | Missense_Mutation | novel | c.470T>G | p.Leu157Arg | p.L157R | Q15050 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
RRS1 | SNV | Missense_Mutation | rs775749259 | c.1031C>A | p.Ser344Tyr | p.S344Y | Q15050 | protein_coding | deleterious_low_confidence(0.02) | benign(0.062) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |